CYP3A but not P ‐gp plays a relevant role in the in vivo intestinal and hepatic clearance of the delta‐specific phosphoinositide‐3 kinase inhibitor leniolisib

Biopharmaceutics&Drug Disposition,Volume 0, Issue ja, -Not available-.

Source: Biopharmaceutics and Drug Disposition - September 1, 2018 Category: Drugs & Pharmacology Authors: StefanDe Buck , KlausKucher , HisanoriHara , CathyGray , RalphWoessner Source Type: research